TY  - GEN
AU  - Moehler,M
AU  - Mueller,A
AU  - Trarbach,T
AU  - Lordick,F
AU  - Seufferlein,T
AU  - Kubicka,S
AU  - Geißler,M
AU  - Schwarz,S
AU  - Galle,P R
AU  - Kanzler,S
TI  - Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
SN  - 1569-8041
PY  - 2011///1128
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - Cetuximab
KW  - Esophageal Neoplasms
KW  - drug therapy
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Irinotecan
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Stomach Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdq591
ER  -